Terms: = Head and neck cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
59 results:
1. Targeting nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract] [Full Text] [Related]
2. m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/nrf2 pathways.
Zhao K; Chen L; Xie Y; Ren N; Li J; Zhai X; Zheng S; Liu K; Wang C; Qiu Q; Peng X; Wang W; Liu J; Che Q; Fan J; Hu H; Liu M
Cancer Lett; 2024 Apr; 587():216735. PubMed ID: 38369001
[TBL] [Abstract] [Full Text] [Related]
3. Uncovering immune checkpoint heterogeneity in oral squamous cell carcinoma using single cell RNA-sequencing data highlights three subgroups of patients with distinct immune phenotypes.
Le Meitour Y; Foy JP; Guinand M; Michon L; Karabajakian A; Fayette J; Saintigny P; Mahtouk K
Oral Oncol; 2024 Feb; 149():106680. PubMed ID: 38218022
[TBL] [Abstract] [Full Text] [Related]
4. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via nrf2-GPX2 Molecular Axis in head-neck cancer.
You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
[TBL] [Abstract] [Full Text] [Related]
5. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
[TBL] [Abstract] [Full Text] [Related]
6. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2 transcription.
Nie Q; Cao H; Yang J; Liu T; Wang B
PeerJ; 2023; 11():e16140. PubMed ID: 37810778
[TBL] [Abstract] [Full Text] [Related]
8. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/nrf2 signaling.
Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
[TBL] [Abstract] [Full Text] [Related]
9. Human papillomavirus-driven repression of nrf2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract] [Full Text] [Related]
10. nrf2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
Gao Y; Wan L; Li M; Wang B; Ma Y
Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
Gao Y; Li M; Wang B; Ma Y
Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
[TBL] [Abstract] [Full Text] [Related]
12. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
13. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming.
Ma Y; Zhang X; Han X; Hao Z; Ji R; Li J; Guo W; Zhang Y; Guan F; Ma S
Mol Carcinog; 2023 Jun; 62(6):866-881. PubMed ID: 36988347
[TBL] [Abstract] [Full Text] [Related]
14. Repurposed pizotifen malate targeting nrf2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K
Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865
[TBL] [Abstract] [Full Text] [Related]
15. Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2-related factor 2-mediated reactive oxygen species increment.
Chen J; Zhang Y; Huang R; Cao L; Zhang Y; Lian M; Wang Z; Jin J; Tang C; Chen T; Yan L; Yu L; Tian R; Xiang X; Luo L; Yu C
Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):253-262. PubMed ID: 36507595
[TBL] [Abstract] [Full Text] [Related]
16. Clinical and Genomic Analysis of Patients with Short Survival after Surgery for Esophageal Squamous Cell Carcinoma.
Gao L; Guo RY; Lu H; Shi ZH; Liu JF
Dig Dis; 2023; 41(3):353-361. PubMed ID: 36412562
[TBL] [Abstract] [Full Text] [Related]
17. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract] [Full Text] [Related]
18. Dysregulation of SOX17/nrf2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
[TBL] [Abstract] [Full Text] [Related]
19. Caspase-8 mutants activate nrf2 via phosphorylating SQSTM1 to protect against oxidative stress in esophageal squamous cell carcinoma.
Li L; Feng R; Li Y; Yu X; Liu Y; Zhao Y; Liu Z
Free Radic Biol Med; 2022 Nov; 192():51-62. PubMed ID: 36165926
[TBL] [Abstract] [Full Text] [Related]
20. MYH9 Facilitates Cell Invasion and Radioresistance in head and neck cancer via Modulation of Cellular ROS Levels by Activating the MAPK-nrf2-GCLC Pathway.
You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
[TBL] [Abstract] [Full Text] [Related]
[Next]
